• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

相似文献

1
Reply to: 'No evidence for an increased liver uptake of SARS-CoV-2 in metabolic-associated fatty liver disease'.回复：“无证据表明代谢相关脂肪性肝病中严重急性呼吸综合征冠状病毒2（SARS-CoV-2）的肝脏摄取增加” 。
J Hepatol. 2020 Sep;73(3):718-719. doi: 10.1016/j.jhep.2020.04.039. Epub 2020 May 6.
2
No evidence for an increased liver uptake of SARS-CoV-2 in metabolic-associated fatty liver disease.在代谢相关脂肪性肝病中，没有证据表明严重急性呼吸综合征冠状病毒2（SARS-CoV-2）的肝脏摄取增加。
J Hepatol. 2020 Sep;73(3):717-718. doi: 10.1016/j.jhep.2020.04.035. Epub 2020 Apr 30.
3
Health status of patients with autoimmune liver disease during SARS-CoV-2 outbreak in northern Italy.意大利北部新冠疫情期间自身免疫性肝病患者的健康状况
J Hepatol. 2020 Sep;73(3):702-705. doi: 10.1016/j.jhep.2020.05.008. Epub 2020 May 12.
4
COVID 19 and the Liver.新型冠状病毒肺炎与肝脏
J Assoc Physicians India. 2020 Nov;68(11):11-12.
5
COVID-19: An Overview of Worldwide Recommendations for Management of Patients With Liver Diseases or Liver Transplantation.2019冠状病毒病：全球肝病或肝移植患者管理建议概述
Clin Gastroenterol Hepatol. 2020 Sep;18(10):2381-2384.e10. doi: 10.1016/j.cgh.2020.04.074. Epub 2020 May 12.
6
Reply to: "Clinical characteristics of COVID-19 patients with abnormal liver tests".回复：“肝功能检查异常的新型冠状病毒肺炎患者的临床特征”
J Hepatol. 2020 Sep;73(3):713-714. doi: 10.1016/j.jhep.2020.04.042. Epub 2020 May 6.
7
Gastrointestinal and liver involvement in patients with COVID-19 - Authors' reply.新型冠状病毒肺炎患者的胃肠道和肝脏受累——作者回复
Lancet Gastroenterol Hepatol. 2020 Sep;5(9):799-800. doi: 10.1016/S2468-1253(20)30240-5.
8
Direct or Collateral Liver Damage in SARS-CoV-2-Infected Patients.SARS-CoV-2 感染患者的直接或间接肝损伤。
Semin Liver Dis. 2020 Aug;40(3):321-330. doi: 10.1055/s-0040-1715108. Epub 2020 Sep 4.
9
Treatments for COVID-19: emerging drugs against the coronavirus - reply.新型冠状病毒肺炎的治疗方法：对抗冠状病毒的新型药物——回复
Acta Biomed. 2020 Jun 30;91(3):ahead of print. doi: 10.23750/abm.v91i3.10108.
10
[The protocol for prevention, diagnosis and treatment of liver injury in coronavirus disease 2019].[新型冠状病毒肺炎肝损伤防治专家共识]
Zhonghua Gan Zang Bing Za Zhi. 2020 Mar 20;28(3):217-221. doi: 10.3760/cma.j.cn501113-20200309-00095.

引用本文的文献

1
Clinical implications of COVID-19 in patients with metabolic-associated fatty liver disease.COVID-19 对代谢相关脂肪性肝病患者的临床影响。
World J Gastroenterol. 2023 Jan 21;29(3):487-502. doi: 10.3748/wjg.v29.i3.487.
2
Adipose tissue dysfunction and MAFLD in obesity on the scene of COVID-19.肥胖症中脂肪组织功能障碍与 MAFLD 与 COVID-19 共舞。
Clin Res Hepatol Gastroenterol. 2022 Mar;46(3):101807. doi: 10.1016/j.clinre.2021.101807. Epub 2021 Sep 17.
3
Nonalcoholic fatty liver disease and COVID-19: An epidemic that begets pandemic.非酒精性脂肪性肝病与2019冠状病毒病：一种引发大流行的流行病。
World J Clin Cases. 2021 Jun 16;9(17):4133-4142. doi: 10.12998/wjcc.v9.i17.4133.
4
Maximum chest CT score is associated with progression to severe illness in patients with COVID-19: a retrospective study from Wuhan, China.最大胸部 CT 评分与 COVID-19 患者进展为重症相关：来自中国武汉的回顾性研究。
BMC Infect Dis. 2020 Dec 11;20(1):953. doi: 10.1186/s12879-020-05683-3.
5
Liver stiffness by transient elastography accompanies illness severity in COVID-19.经瞬时弹性成像测得的肝脏硬度与新冠病毒病（COVID-19）的疾病严重程度相关。
BMJ Open Gastroenterol. 2020 Jul;7(1). doi: 10.1136/bmjgast-2020-000445.
6
COVID-19 and non-alcoholic fatty liver disease: Two intersecting pandemics.COVID-19 与非酒精性脂肪性肝病：两大流行病的交集。
Eur J Clin Invest. 2020 Oct;50(10):e13338. doi: 10.1111/eci.13338. Epub 2020 Aug 26.

本文引用的文献

1
No evidence for an increased liver uptake of SARS-CoV-2 in metabolic-associated fatty liver disease.在代谢相关脂肪性肝病中，没有证据表明严重急性呼吸综合征冠状病毒2（SARS-CoV-2）的肝脏摄取增加。
J Hepatol. 2020 Sep;73(3):717-718. doi: 10.1016/j.jhep.2020.04.035. Epub 2020 Apr 30.
2
Prediction for Progression Risk in Patients With COVID-19 Pneumonia: The CALL Score.COVID-19 肺炎患者进展风险预测：CALL 评分。
Clin Infect Dis. 2020 Sep 12;71(6):1393-1399. doi: 10.1093/cid/ciaa414.
3
Gastrointestinal Manifestations of SARS-CoV-2 Infection and Virus Load in Fecal Samples From a Hong Kong Cohort: Systematic Review and Meta-analysis.香港队列粪便样本中 SARS-CoV-2 感染的胃肠道表现及病毒载量：系统评价与荟萃分析
Gastroenterology. 2020 Jul;159(1):81-95. doi: 10.1053/j.gastro.2020.03.065. Epub 2020 Apr 3.
4
Macrophages in obesity and non-alcoholic fatty liver disease: Crosstalk with metabolism.肥胖与非酒精性脂肪性肝病中的巨噬细胞：与代谢的相互作用
JHEP Rep. 2019 Feb 23;1(1):30-43. doi: 10.1016/j.jhepr.2019.02.004. eCollection 2019 May.
5
Impact of Obesity on Influenza A Virus Pathogenesis, Immune Response, and Evolution.肥胖对甲型流感病毒发病机制、免疫反应和进化的影响。
Front Immunol. 2019 May 10;10:1071. doi: 10.3389/fimmu.2019.01071. eCollection 2019.
6
Liver: An organ with predominant innate immunity.肝脏：一个具有主要固有免疫的器官。
Hepatology. 2008 Feb;47(2):729-36. doi: 10.1002/hep.22034.

Reply to: 'No evidence for an increased liver uptake of SARS-CoV-2 in metabolic-associated fatty liver disease'.

作者信息

Ji Dong, Xu Jing, Qin Enqiang, Zhang Dawei, Cheng Gregory, Wang Yudong, Lau George

机构信息

The Fifth Medical Center of Chinese PLA General Hospital, Beijing 100039, China.

Fuyang Second People's Hospital, Fuyang, Anhui 236000, China.

出版信息

J Hepatol. 2020 Sep;73(3):718-719. doi: 10.1016/j.jhep.2020.04.039. Epub 2020 May 6.

DOI:10.1016/j.jhep.2020.04.039
PMID:32387073
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7200372/
Abstract
摘要